BrainsWay Ltd.
HealthcareNASDAQ:BWAY · NASDAQ Global Market
-$0.06 today
Vol 0.04M · Avg 0.16M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $58.6M |
| Short-term Investments | $1.1M |
| Receivables | $7.5M |
| Inventory | $7.1M |
| Other Current | $4.2M |
| Total Current Assets | $78.6M |
| PP&E (Net) | $12.9M |
| Long-term Investments | $23.2M |
| Other Non-current | $2.3M |
| Total Non-current Assets | $38.4M |
| Total Assets | $117.0M |
Analysis
Selected assets total $117.0M for Latest. The largest visible component is Cash & Equivalents at $58.6M, about 50.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $67.7M -2.4% | $69.3M +559.2% | $10.5M -77.9% | $47.6M +181.2% | $16.9M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $1.4M | $0 -100.0% | $35.5M | $0 -100.0% | $40.4M | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $4.1M -10.6% | $4.6M +21.6% | $3.8M -22.0% | $4.8M -23.5% | $6.3M | $533.8M | $399.4M | -$1.7B |
| Inventory | $7.1M +61.2% | $4.4M +19.1% | $3.7M -3.1% | $3.8M +1818.5% | $200.0K | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $4.5M +246.3% | $1.3M +88.6% | $691.0K -62.2% | $1.8M +370.9% | $388.0K | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $84.9M +6.6% | $79.7M +43.6% | $55.5M -4.5% | $58.1M -11.2% | $65.4M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $12.2M +1.8% | $11.9M +106.4% | $5.8M +8.3% | $5.3M -42.7% | $9.3M | $1.2B | $1.5B | $687.8M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $14.3M | $0 | $0 | $0 | $0 | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 -100.0% | $1.1M | $0 -100.0% | $276.0K | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $1.5M -6.9% | $1.6M -4.8% | $1.7M +124.2% | $766.0K -19.7% | $954.0K | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $28.0M +91.4% | $14.6M +95.1% | $7.5M +17.5% | $6.4M -37.9% | $10.3M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $112.9M +19.7% | $94.3M +49.8% | $63.0M -2.3% | $64.5M -14.9% | $75.7M | $13.3B | $11.9B | $10.6B |
| Account Payables | $2.4M -15.3% | $2.9M +278.4% | $758.0K -32.1% | $1.1M +1.3% | $1.1M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $0 | $0 | $0 | $0 | $0 | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 -100.0% | $268.0K -46.8% | $504.0K | $0 -100.0% | $18.0K | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $12.2M +113.5% | $5.7M | $0 -100.0% | $1.5M -32.7% | $2.2M | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $0 -100.0% | $2.7M -33.1% | $4.1M +39.2% | $2.9M +38.2% | $2.1M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $22.2M +44.4% | $15.3M +57.2% | $9.8M +19.9% | $8.1M -10.2% | $9.1M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $0 | $0 | $0 | $0 | $0 | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $11.8M +25.1% | $9.4M +77.4% | $5.3M +13.8% | $4.7M +47.9% | $3.2M | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $0 -100.0% | $2.4M -60.0% | $6.1M +1.0% | $6.0M +1.5% | $5.9M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $17.5M +5.3% | $16.7M +43.2% | $11.6M +6.3% | $10.9M +17.1% | $9.3M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $39.7M +24.0% | $32.0M +49.6% | $21.4M +12.1% | $19.1M +3.7% | $18.4M | $14.7B | $3.7B | $9.6B |
| Common Stock | $430.0K +4.1% | $413.0K +12.5% | $367.0K +0.8% | $364.0K +0.3% | $363.0K | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$90.7M +7.8% | -$98.4M +2.9% | -$101.3M -4.3% | -$97.1M -15.9% | -$83.8M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | -$2.2M +0.0% | -$2.2M +0.0% | -$2.2M +0.0% | -$2.2M +0.0% | -$2.2M | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $3.5M -28.0% | $4.9M +11.7% | $4.4M -29.4% | $6.2M +15.7% | $5.3M | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $73.2M +17.5% | $62.3M +49.9% | $41.6M -8.4% | $45.4M -20.8% | $57.3M | $9.1B | $7.7B | $3.3B |
| Total Debt | $6.8M +21.2% | $5.6M +1094.1% | $471.0K -3.5% | $488.0K -35.3% | $754.0K | $724.2M | $410.6M | $399.4M |
| Net Debt | -$60.9M +4.5% | -$63.7M -534.1% | -$10.0M +78.7% | -$47.1M -191.3% | -$16.2M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Tactile Systems Technology, Inc.
NASDAQ:TCMD
$593.46M
NeuroPace, Inc.
NASDAQ:NPCE
$533.23M
Cerus Corporation
NASDAQ:CERS
$512.94M
Delcath Systems, Inc.
NASDAQ:DCTH
$404.59M
Viemed Healthcare, Inc.
NASDAQ:VMD
$400.62M
908 Devices Inc.
NASDAQ:MASS
$312.72M
Senseonics Holdings, Inc.
NASDAQ:SENS
$299.93M
Sight Sciences, Inc.
NASDAQ:SGHT
$279.12M
RxSight, Inc.
NASDAQ:RXST
$194.98M
CVRx, Inc.
NASDAQ:CVRX
$133.48M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does BWAY have?
BrainsWay Ltd. (BWAY) reported $67.70M in cash and equivalents in fiscal 2025.
How much debt does BWAY carry?
BrainsWay Ltd. (BWAY) reported $6.82M of total debt, with net debt of -$60,883,000.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.